Reply to Sfeir
Clin Infect Dis
.
2021 Apr 26;72(8):1485-1486.
doi: 10.1093/cid/ciaa881.
Authors
Johann Motsch
1
,
Katherine Young
2
,
Michelle L Brown
2
,
Joan R Butterton
2
,
Amanda Paschke
2
Affiliations
1
Universitätsklinikum Heidelberg, Heidelberg, Germany.
2
Merck & Co, Inc, Kenilworth, New Jersey, USA.
PMID:
32634242
DOI:
10.1093/cid/ciaa881
No abstract available
Publication types
Letter
Kommentar
MeSH terms
Azabicyclo Compounds
Bacterial Infections*
Colistin*
Double-Blind Method
Humans
Imipenem
Substances
Azabicyclo Compounds
Imipenem
relebactam
Colistin